{"database": "lobbying", "table": "lobbying_activities", "rows": [[600968, "4b9193e8-486f-4614-85ee-0559c7a33f33", "Q1", "GENENTECH, INC", 15920, "GENENTECH INC", 2008, "first_quarter", "PHA", "H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics\nH.R. 1956, patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics\nH.R. 5629, Pathway for Biosimilars Act\nS. 1505 Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price competition and Innovation Act of 207, follow-on biologics\nS. 2029, Physician Payments Sunshine Act of 2007\nS. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions\nS. 623, Access to Life-Saving Medicine Act, follow-on biologics\nS. 877, Controlling Abuse of Prescription Drugs Act of 2007\nH.r. 4911, Human Growth Hormone Restriction Act of 2007", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE", null, 591000, 0, 0, "2008-04-18T15:27:48-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["600968"], "units": {}, "query_ms": 3.4651129972189665, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}